Take-home message {#d29e402}
=================

Nearly 50% of sepsis survivors have at least one unplanned rehospitalisation by 1 year following hospital discharge from their index sepsis admission.Many of the risk factors for this rehospitalisation are acute illness characteristics at index sepsis admission such as age, comorbidities, site of infection, and illness severity.

Introduction {#Sec2}
============

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection \[[@CR1]\] and is a global health priority \[[@CR2]\]. In cohort studies, mainly from critically ill adults from high-income countries, sepsis diagnosis is increasing, and short-term mortality is improving \[[@CR3]--[@CR5]\]. This epidemiology pattern results in increasing numbers of sepsis survivors, defined as patients who survive a sepsis-related hospitalisation. Among the numerous long-term ill health consequences observed in sepsis survivors, increased risk of rehospitalisation and long-term mortality \[[@CR6]\], when compared with non-sepsis hospitalisations and age-sex matched general population, are major challenges \[[@CR7], [@CR8]\]. Importantly, a proportion of this increased risk of rehospitalisation in sepsis survivors may be modifiable \[[@CR9]\].

Similar to the challenge of determining causation with the reported associations between sepsis and long-term mortality \[[@CR10]\], the risk of rehospitalisation in sepsis survivors may be sepsis-related or may reflect an event that is common to anyone who survives a hospitalisation episode \[[@CR11]\]. Thus, we hypothesised that this rehospitalisation risk in sepsis survivors may vary with both patient characteristics and health care system characteristics \[[@CR12], [@CR13]\]. Therefore, understanding the independent and potentially modifiable risk factors that contribute towards this additional rehospitalisation risk seen in sepsis survivors would inform future interventional trials aimed at reducing this risk.

In this context, the first aim of our systematic review was to assess the rehospitalisation rate, the associated major rehospitalisation diagnoses, and the excess risk of all-cause rehospitalisation due to sepsis in sepsis survivors using studies reporting comparator populations. The second aim was to assess the independent risk factors for rehospitalisation using studies that report design features or analytic approach to control confounding \[[@CR14], [@CR15]\], such as use of comparator populations, matching, restriction, stratification, and regression. The third aim was to assess how studies handled the competing risk of mortality in sepsis survivors, when rehospitalisation events are studied as the outcome of interest \[[@CR10], [@CR16], [@CR17]\]. This competing risk problem may be more common in health care settings where community-level end-of-life or hospice care is more prevalent \[[@CR18], [@CR19]\].

Methods {#Sec3}
=======

Our study conforms to the MOOSE checklist for systematic reviews of observational studies \[[@CR20]\].

Information sources {#Sec4}
-------------------

Using the OVID interface, we searched for non-randomized studies and randomized clinical trials (RCTs) published since 1992 in the following databases: MEDLINE (including in-process and non-indexed citations), Cochrane Library and its associated databases (including Database of Abstracts of Reviews of Effects (DARE), Web of Science, and EMBASE. The search strategy used controlled vocabulary terms and text words for sepsis and hospital readmission, and the search set was limited to humans and English language. Subject headings were exploded and mapped to the appropriate controlled vocabulary terms. The year 1992 was chosen to coincide with the year of publication of the first consensus sepsis definitions \[[@CR21]\]. The full electronic search strategy for MEDLINE is presented in electronic supplementary material (eTable-1) and modified for other databases and registered with the International prospective register of systematic reviews (PROSPERO CRD 42016039257). The initial literature search was on 31st March 2017 and was updated on 5th October 2019.

Study selection {#Sec5}
---------------

Two reviewers (RS, MSH) independently screened citations for those reporting all-cause rehospitalisation for sepsis survivor populations in the title or abstract; the full text of any citation considered potentially relevant by either reviewer was retrieved. Eligible studies had a cohort, case--control, or Randomised-Controlled Trial (RCT) design; enrolled hospital survivors of an admission for sepsis; and reported all-cause readmission. An eligible RCT would have enrolled sepsis survivors and examined any intervention. The PICO framework for study selection is reported in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1PICO summary and approach to research question. The principal *exposure* was surviving an index sepsis-related hospitalisation (sepsis survivors). The outcome of interest was all-cause rehospitalisation, which will be affected by **a** survivorship bias in the observed associations, as sepsis survivors are likely to be healthier than patients who die during the sepsis-related hospitalisation and **b** bias from competing risk as sepsis survivors also have a long-term risk of mortality. Shorter follow-up times in rehospitalisation studies preclude observation of outcome of interest (i.e., censored outcomes). A = Sepsis cohort starting from their index admission which may have greater risk of survivorship bias; B = Ideal cohort to address the research question; and C = Re-hospitalised survivor cohort all patients have the outcome of interest and there is limited understanding of the competing risk issue. Studies with non-sepsis controls provide an estimate the excess risk of rehospitalisation that is unique to sepsis \[[@CR10], [@CR87]\]

For inclusion into the systematic review, sepsis was defined as infection-related organ dysfunction \[[@CR1]\] managed in hospital setting and includes studies that used the equivalent terminology of sepsis, severe sepsis, and septic shock \[[@CR1], [@CR22]\]. We excluded studies restricted to children and to special populations such as those with retroviral disease, cancer, and other immune-compromised states, although studies that enrolled these special populations as part of a more general cohort were eligible for inclusion. We also excluded studies enrolling survivors of uncomplicated infections, such as pneumonia, without referring to organ dysfunction or to International Classification of Diseases (ICD) codes for sepsis, severe sepsis, or septic shock in their index sepsis case definitions. Prior to finalising the literature strategy in October 2016, infection-related rehospitalisation was revised to a secondary outcome; the primary outcome was considered as all-cause rehospitalisation. However, this point was only updated in the PROSPERO record prior to submission for peer review. At the screening stage, we considered any study design and included review articles and editorials accompanying original relevant studies. We also screened reference lists of included studies, related review articles, and editorials.

Data collection and validity assessment {#Sec6}
---------------------------------------

When two or more studies were identified that reported data from the same patient cohort, the most relevant article was chosen by consensus (JW, RS, MSH). The most relevant article was defined as the most recent full manuscript, if the data from the same patient cohort were reported as abstract or as an earlier full manuscript. Three authors (JW, RS, MSH) extracted data from the included studies and issues of uncertainty were resolved by consensus. We included full manuscripts and conference abstracts for estimating the timing and rate of rehospitalisation and only the full manuscripts for assessing rehospitalisation diagnoses, independent risk factors, and the competing risk problem. From each of the included studies, we extracted data on study design, number of patients, duration of follow-up, handling of loss during follow-up, description of index sepsis admission, rehospitalisation events, rehospitalisation diagnoses, independent risk factors for rehospitalisation, and approach to competing risk of long-term mortality \[[@CR8]\]. We classified risk factors as generic, sepsis-related, or hospital-related according to a previously used framework \[[@CR6], [@CR8]\].

Assessment of methodological quality {#Sec7}
------------------------------------

For studies reported as full-text manuscripts, study quality was assessed using domains from the modified Newcastle Ottawa Score (NOS) checklist \[[@CR23]\]. These included domains of patient selection (cohort data source for representativeness of exposed cohort, selection of non-exposed cohort, exposure ascertainment using sepsis definitions or International Classification of Diseases codes), minimum duration of follow-up for outcome to occur was defined as 30 days, assessment of confounding (use of comparator populations, matching, restriction, stratification, and regression), and comparability using non-sepsis controls and outcome (outcome assessment, length, and adequacy of follow-up). The independent risk factors for rehospitalisation were identified from studies that used regression models to account for confounders. We assessed the overall certainty of evidence using the GRADE framework \[[@CR24]\], considering the risk of bias of included studies (as described above), inconsistency, imprecision, indirectness, and publication bias.

Statistics {#Sec8}
----------

Our conceptual approach is summarised in Fig. [1](#Fig1){ref-type="fig"}. The primary outcome of interest was all-cause rehospitalisation events in sepsis survivors following an index episode of sepsis, at follow-up time points as reported in studies. We recategorized the rehospitalisation-associated risk factors into generic, sepsis-specific, and hospital-level factors. We included age, sex, ethnicity, rural or urban residence, socioeconomic status, educational attainment, and comorbidity as generic risk factors. We included infection, septic shock status, acute illness severity including physiological disturbance, organ support, and organ dysfunction as sepsis-specific risk factors. We included hospital location (urban versus rural), university status (university-affiliated vs not), and other reported descriptions as hospital-level risk factors. We provide a descriptive comparison of risk factors included in analysis between studies and those risk factors identified as increasing the risk of rehospitalisation in sepsis survivors between studies. We performed random effect metanalysis of proportions (using metaprop package) \[[@CR25]\] of cumulative rehospitalizations at 7, 30, 90, 180, and 365 days; between-study heterogeneity was assessed using *I*^2^, which is the percentage of between-study variation due to heterogeneity rather than chance, with values of 25%, 50%, and 75% indicating low, moderate, and high heterogeneity, respectively \[[@CR26]\]. We assessed small-study effects using Egger's test for 7-, 30-, 90-, 180-, and 365-day proportions, when there were at least ten studies at a given time point. All analyses were done using Stata/MP 14.2 StataCorp College Station, Texas 77845, USA.

Results {#Sec9}
=======

Study selection {#Sec10}
---------------

The bibliographic database search identified 12,544 records. After exclusion of duplicates, we identified 7,872 records for screening. Following screening, 111 records were considered eligible for full-text evaluation. Based on full-text evaluation, we excluded 56 records (reasons for exclusion reported in Fig. [2](#Fig2){ref-type="fig"} and the excluded papers are referenced in eMethods-1). We included one study from the reference scan of included full manuscripts, resulting in 56 unique studies that met our inclusion criteria for the systematic review (36 full manuscripts \[[@CR9], [@CR12], [@CR13], [@CR27]--[@CR59]\] and 20 conference abstracts \[[@CR60]--[@CR79]\], (Fig. [2](#Fig2){ref-type="fig"}). All studies were observational; we did not identify any RCTs enrolling sepsis survivors.Fig. 2Flow diagram showing literature search and results. Flow of information through the different phases of our systematic review recorded PRISMA reporting guidelines. We identified 5184 records from searching *MEDLINE*, 3810 records from searching *EMBASE,* 474 records from searching *Ovid other/ non-indexed* database, and 2039 records from searching the *Cochrane library*. We identified a further 1037 records from searching the *Web of Science* database (using TOPIC (septic\*) and TOPIC (readmission\*) = 244; TOPIC (sepsis\*) and TOPIC (readmission\*) = 793). This literature search resulted in a total of 12,544 records for our systematic review. ^1^At screening stage, we included original articles, review articles, and editorials. ^2^Reference list from editorial and review articles that met the screening criteria were included for full-text review. ^3^One full manuscript from reference list scan of the 36 included full manuscripts. ^4^Excluded studies are listed in ESM

Methodological quality of included studies {#Sec11}
------------------------------------------

Our study selection criteria ensured that all 36 studies had the exposure of interest, sepsis, thereby avoiding differential exposure measurement that contributes towards risk of bias \[[@CR9], [@CR12], [@CR13], [@CR27]--[@CR59]\]. All 36 studies met the minimum follow-up duration of 30 days \[[@CR9], [@CR12], [@CR13], [@CR27]--[@CR59]\], that we considered as adequate for outcome of interest to occur. Ten studies report a sepsis cohort starting from their index admission \[[@CR27], [@CR35], [@CR37], [@CR41], [@CR44], [@CR46], [@CR50], [@CR51], [@CR53], [@CR55]\], twelve studies report a sepsis survivor cohort \[[@CR9], [@CR12], [@CR30]--[@CR32], [@CR36], [@CR45], [@CR47], [@CR52], [@CR56], [@CR58], [@CR59]\], and four report a rehospitalisation cohort \[[@CR28], [@CR34], [@CR40], [@CR42]\]. Ten were single-centre studies \[[@CR28], [@CR37], [@CR40], [@CR44], [@CR47], [@CR50], [@CR51], [@CR55], [@CR56], [@CR59]\] with greater risk of bias compared to 21 studies \[[@CR9], [@CR12], [@CR13], [@CR27], [@CR29]-[@CR31], [@CR33], [@CR35], [@CR36], [@CR38], [@CR39], [@CR41], [@CR42], [@CR45], [@CR48], [@CR49], [@CR53], [@CR54], [@CR57]\] that used large multi-centre databases with greater generalizability. Five studies that use notes review for outcome assessment \[[@CR28], [@CR37], [@CR40], [@CR51], [@CR55]\] have a greater risk of ascertainment bias, compared to studies that use record linkage outcome assessment. The primary outcome was all-cause rehospitalisation in 21 studies \[[@CR9], [@CR12], [@CR13], [@CR28]-[@CR30], [@CR35], [@CR36], [@CR38], [@CR39], [@CR41], [@CR42], [@CR45], [@CR47], [@CR48], [@CR50]-[@CR52], [@CR56], [@CR57], [@CR59]\]. Confounders for rehospitalisation risk factors were addressed with regression models in seventeen \[[@CR12], [@CR29], [@CR33], [@CR35], [@CR36], [@CR38]--[@CR41], [@CR45], [@CR47], [@CR50]--[@CR52], [@CR55], [@CR56], [@CR59]\] including competing risk models in two \[[@CR38], [@CR41]\], matching in two \[[@CR9], [@CR49]\], stratification in one \[[@CR50]\], and restriction in one \[[@CR33]\]. Twenty-one studies were of low risk of bias and 15 studies were at moderate risk of bias for the primary outcome of rehospitalisation risk, as per modified Newcastle--Ottawa criteria (Table [1](#Tab1){ref-type="table"}).Table 1Quality assessment and overall risk of bias of original research articles included in the systematic reviewStudy IDCohort data sourceCohort descriptionAscertainment of sepsis exposureMinimum 30-day follow-upFollow-up method and outcome assessmentWas primary study outcome all-cause rehospitalisationConfounder assessment for rehospitalisation risk factors in sepsis survivorsNon-sepsis comparisonsOverall risk of biasBraun et al. \[[@CR27]\]MC-largeSepsis cohortYesYesRecord linkageNoNot assessedNoLowCakir et al. \[[@CR28]\]SCRe-hospitalised cohortYesYesNotes reviewYesNot assessedYesModerateChang et al. \[[@CR29]\]MC-largeSepsis and non-sepsis patients in cohortYesYesRecord linkageYesRegressionYesLowDeb P et al. \[[@CR30]\]MC-largeSepsis survivorsYesYesRecord linkageYesRegressionNoLowDeMerle et al. \[[@CR31]\]MC-largeSepsis survivorsYesYesRecord linkageNoNot assessedNoLowDeMerle et al. \[[@CR32]\]SCSepsis survivorsYesYesNotes reviewNoNot assessedNoLowDick et al. \[[@CR33]\]MC-largeSepsis and non-sepsis patientsYesYesRecord linkageNoNot assessedYesLowDietz et al. \[[@CR34]\]MCRe-hospitalised cohortYesYesEHRNoNot assessedYesLowDonnelly et al. \[[@CR12]\]MC-largeSepsis survivorsYesYesRecord linkageYesRegressionNoLowGadre et al. \[[@CR35]\]MC-largeSepsis cohortYesYesRecord linkageYesRegressionNoLowGoodwin et al. \[[@CR36]\]MC-largeSepsis survivorsYesYesRecord linkageYesRegressionNoLowGuirgis et al. \[[@CR37]\]SCSepsis cohortYesYesNotes reviewNoNot assessedNoModerateHua et al. \[[@CR38]\]MC-largeSepsis and non-sepsis patients in cohortYesYesRecord linkageYesRegression; competing risk modelYesLowJones et al. \[[@CR39]\]MC-largeSepsis and non-sepsis patients in cohortYesYesRecord linkageYesRegressionYesLowKim et al. \[[@CR40]\]SCRe-hospitalised cohortYesYesNotes reviewNoRegressionNoModerateLiu et al. \[[@CR41]\]MC-largeSepsis cohortYesYesRecord linkageYesRegression; competing risk modelNoLowMayr et al. \[[@CR42]\]MC-largeRe-hospitalised cohortYesYesRecord linkageYesNot assessedYesLowMeyer et al. \[[@CR43]\]MCSepsis and non-sepsis patients in cohortYesYesRecord linkageNoNot assessedYesLowNkemdirim Okere et al. \[[@CR44]\]SCSepsis cohortYesYesRecord linkageNoRestriction; not assessedNoModerateNorman et al. \[[@CR45]\]MC-largeSepsis survivorsYesYesRecord linkageYesRegressionNoLowNsutebu et al. \[[@CR46]\]MCSepsis cohortYesYesNotes reviewNoNot assessedNoModerateOrtego et al. \[[@CR47]\]SCSepsis survivorsYesYesRecord linkageYesRegressionNoLowPrescott et al. \[[@CR49]\]MC-largeSepsis and non-sepsis patients in cohortYesYesRecord linkageNoMatchingYesLowPrescott et al. \[[@CR9]\]MC-LargeSepsis and non-sepsis patients in cohortYesYesRecord linkageYesMatchingYesLowPrescott et al. \[[@CR48]\]MC-largeSepsis and non-sepsis patients in cohortYesYesRecord linkageYesNot assessedYesModeratePrescott et al. \[[@CR13]\]MC-largeSepsis survivorsYesYesRecord linkageYesNot assessedNoModerateSchnegelsberg et al. \[[@CR50]\]SCSepsis cohortYesYesRecord linkageYesStratificationNoModerateSingh et al. \[[@CR51]\]SCSepsis cohortYesYesNotes reviewYesRegressionNoModerateSun A et al. \[[@CR52]\]MCSepsis survivorsYesYesNotes reviewYesRegressionNoModerateSutton et al. \[[@CR53]\]MC-LargeSepsis cohortYesYesRecord linkageNoNot assessedNoModerateVashi et al. \[[@CR54]\]MC-largeSepsis and non-sepsis patients in cohortYesYesRecord linkageNoNot assessedYesLowWang et al. \[[@CR55]\]SCSepsisYesYesNotes reviewNoRegressionYesModerateWeinreich et al. \[[@CR56]\]SCSepsis survivorsYesYesHospital EHRYesRegressionNoModerateWong EL et al. \[[@CR57]\]MC-largeSepsis and non-sepsis patients in cohortYesYesRecord linkageYesNot assessedYesModerateYende et al. \[[@CR58]\]MCSepsis survivorsYesYesProspective cohortNoNot assessedNoLowZilberberg et al. \[[@CR59]\]SCSepsis survivorsYesYesHospital EHRYesRegressionNoModerateThe risk of bias was assessed on patient selection, ascertainment of exposure, and ascertainment of outcome domains using a modified Newcastle Ottawa Score (NOS) quality assessment checklist \[[@CR23]\]. These domains account for bias with ascertainment, generalisability, measurement of exposure, measurement of risk factors, and selection. Comparability domain of NOS assessed whether excess risk of rehospitalisation in sepsis survivors was quantified and how confounders were considered during study design or analysis with techniques such as matching, restriction or regression models. Outcome domain of NOS assessed bias due to incomplete assessment of outcome or of competing risk outcomes such as mortality and due to censoring**.** Study-level risk of bias is then reported. Using this information, overall certainty of evidence was assessed as per GRADE system of assessment of evidence about prognosis (see main results) \[[@CR24]\]*EHR* electronic health record, *MC* multi-centre, *SC* single-centre

Primary outcome (rate of all-cause rehospitalisation) {#Sec12}
-----------------------------------------------------

Studies most often reported the 30-day rehospitalisation events in a sepsis survivor population. The mean rehospitalisation proportion (95% CI) at 30 days was 21.4% (17.6%, 25.4%; *N* = 36 studies reporting 6,729,617 patients; Fig. [3](#Fig3){ref-type="fig"}), at 7 days was 9.3% (8.3%, 10.3%; *N* = 5 studies reporting 475,312 patients), at 90 days was 38.1% (34.3%, 42.0%; *N* = 14 studies, 388,044 patients), at 180 days was 36.2% (30.7%, 41.8%; *N* = 7 studies, 107,293 patients), and at 365 days was 39.0% (22.0%; 57.4%; *N* = 5 studies, 10,286 patients). All estimates had high heterogeneity. We did not observe any small-study effects (eTable-1). Two studies that use competing risk models \[[@CR38], [@CR41]\] also had similar 30-day rehospitalisation rates (eFigure-1; test for heterogeneity between groups *p* = 0.08). There were no differences in 30-day rehospitalisation rates by risk of bias (eFigure-2; test for heterogeneity between groups *p* = 0.33). In studies with non-sepsis comparator populations, the 30-day rehospitalisation proportions in sepsis survivors were reported as either comparable to congestive heart failure and acute myocardial infarction \[[@CR9], [@CR29], [@CR54]\], or much higher than these and other similar acute medical conditions \[[@CR33], [@CR34], [@CR39], [@CR42], [@CR55], [@CR57]\]. The median (IQR) acute mortality among sepsis survivors who were re-hospitalised was 6.6% (4.6%, 8.7%; *N* = 8 studies) \[[@CR12], [@CR13], [@CR29], [@CR34], [@CR36], [@CR38], [@CR39], [@CR57]\].Fig. 3Rate and timing of rehospitalisation. Random effect meta-analysis of proportions by rehospitalisation interval reported in all studies

Diagnosis at rehospitalisation {#Sec13}
------------------------------

Studies that report rehospitalisation diagnoses in sepsis survivors grouped these diagnoses using clinical classification software (CCS) codes \[[@CR29], [@CR35], [@CR38], [@CR41]\], ambulatory care sensitive conditions codes (ACSCs) \[[@CR9]\], or other customised categories \[[@CR13], [@CR47], [@CR52]\] (Table [2](#Tab2){ref-type="table"}). The relationship between infection at index sepsis admission and the infection diagnosis at rehospitalisation was reported in one study as recurrent or unresolved in nearly 50% of cases \[[@CR52]\], often secondary to opportunistic pathogens like *Pseudomonas aeruginosa* and Candida species in another study \[[@CR55]\], and same site as index sepsis admission in 68% of rehospitalisation events in another study \[[@CR32]\]. Infection-related rehospitalisation was the most common rehospitalisation event in sepsis survivors. The median (IQR) 30-day event rate was 49.3% (38.0%, 61.2%) of the all rehospitalisation events in ten studies \[[@CR12], [@CR29], [@CR34]--[@CR36], [@CR38], [@CR47], [@CR51], [@CR52], [@CR56]\], with similar proportions reported at 90 days \[[@CR37], [@CR40]\] and 365 days \[[@CR41]\]. Between one-third and two-thirds of rehospitalisation episodes in sepsis survivors were coded as sepsis \[[@CR29], [@CR32], [@CR52]\] (Table [2](#Tab2){ref-type="table"}).Table 2Rehospitalization diagnosis according to diagnostic classification scheme used in selected studiesCCS criteriaLiu V et al. \[[@CR41]\]\
*N* = 4310a\
Liberal at 1-yearChang DW et al. \[[@CR29]\]\
*N* = 240,198^a^\
At 30 daysGadre SK et al. \[[@CR35]\]\
*N* = 1,030,335\
At 30 daysTop-10 ACSCsPrescott H et al. \[[@CR9]\]\
*N* = 2617^b^OtherPrescott H et al. \[[@CR13]\]\
*N* = 16,844\
(2011 data at 90 days)Ortego A et al. \[[@CR47]\]\
*N* = 63a\
At 30 daysSun et al. \[[@CR52]\]\
*N* = 104a\
At 30 daysHua M et al. \[[@CR38]\]\
*N* = 44,051\
At 30 daysInfectious42.7%59.3%42.2%Sepsis6.4%Infections14.3%46%69.2%25.5%Circulatory13.6%6.8%8.7%CHF5.5%Cardiovascular and thromboembolic7.4%17.5%12.5%29.5%Respiratory9%12.8%7.8%Pneumonia3.5%Acute Kidney injury or Genitourinary4.4%6.4%5.8%2.7%Digestive6.6%3.1%9.6%Acute renal failure3.3%Complications of devices2.7%3.2%3.8%4.7%Injury and poisoning8.9%Rehabilitation2.8%Other4.8%8.6%Genitourinary2.6%5%5%Acute Respiratory failure2.5%Complication of procedure2.8%15.3%Endocrine and metabolic4.6%Complications2%Respiratory6.6%6.4%Neoplastic4.1%COPD Exacerbation1.9%Fluid and electrolyte disorder2.6%Dermatologic0.4%Aspiration pneumonitis1.8%Related to comorbid condition22.2%Musculoskeletal1.7%UTI1.7%Diabetes Mellitus complications2.7%Hematologic1.9%Fluid or electrolyte disorderGastrointestinal2.5%Nervous system1.6%All others1.2%13.9%*CCS* Clinical classification software diagnostic categories, *ASCS* ambulatory care sensitive conditions, *CHF* congestive heart failure, *COPD* chronic obstructive pulmonary disease, *UTI* urinary tract infections

Independent risk factors for all-cause rehospitalisation {#Sec14}
--------------------------------------------------------

Among the 15 studies that identify independent risk factors for rehospitalisation events in sepsis survivors \[[@CR12], [@CR29], [@CR30], [@CR35], [@CR36], [@CR38]-[@CR41], [@CR45], [@CR51], [@CR52], [@CR55], [@CR56], [@CR59]\], most analysed all-cause 30-day rehospitalisation as the outcome and two studies report independent risk factors for infection-related rehospitalisation \[[@CR40], [@CR55]\] (Table [3](#Tab3){ref-type="table"}). Generic characteristics consistently highlighted as predictors for increased risk of rehospitalisation were increasing age, male sex, presence of one or comorbidities determined using either Charlson or Elixhauser comorbidity indices, non-white race, non-elective admissions, pre-index admission hospitalisation, and increased length of hospitalisation during index sepsis admission. Risk of rehospitalisation in sepsis survivors was increased when the discharge location was not to home following the index sepsis admission \[[@CR13], [@CR30], [@CR34]-[@CR36], [@CR38], [@CR51]\]. Table 3Summary of full manuscripts included in the systematic review and risk factors for *increased* risk of rehospitalisation in studies reporting regression modelsStudy ID and CountryStudy characteristicsRegression model for the outcome as reported in studiesRisk factors associated with increased risk of rehospitalisation in studies reporting regression models for rehospitalisation outcomes and risk factors for primary outcome for individual studiesData source and sample size (*N* =)Study primary outcomeGenericSepsis-specificHospital and other characteristicsBraun et al. \[[@CR27]\]USAAdministrative claims data (not Managed Medicare)*N* = 2,834Hospital length of stay and health service costs due to admission with severe sepsisNoNot applicableNot applicableNot applicableCakir et al. \[[@CR28]\]USASingle-centre community hospital data*N* = 5,20630-day rehospitalisation with same diagnosis as index hospitalisationNoNot applicableNot applicableNot applicableChang et al. \[[@CR29]\]USAHealthcare Cost and Utilisation Project data*N* = 240,198 sepsis patientsAll-cause 30-day readmission after hospitalisation with sepsisMixed-effects logistic regression for 30-day rehospitalisationYounger ageMaleBlack or Native AmericanHigher burden of comorbiditiesNo independent associations reportedHospitals serving higher proportion of minorities; For profit hospitalsUniversity hospital; Urban residence; Lower incomeDeb et al. \[[@CR30]\]USAMedicare data*N* = 170,57130-day all-cause hospital readmissionMultinomial logit model of 30-day study outcome categoriesComorbidities; unplanned weight loss; ADL dependencies;Organ dysfunction (referred to as severe sepsis)Home health nursing assessment of risk;DeMerle et al. \[[@CR31]\]Veterans Affairs data*N* = 26,561Days spent in a healthcare facilityNoNot applicableNot applicableNot applicableDeMerle et al. \[[@CR32]\]University of Michigan Health System*N* = 47290-day infection-related rehospitalisation characteristicsNoNot applicableNot applicableNot applicableDick et al. \[[@CR33]\]USAMedicare data*N* = 17,537Survival and healthcare utilization for five years following index admission with sepsis, pneumonia, CLABSI or VAPNoNot applicableNot applicableNot applicableDietz et al. \[[@CR34]\]USAUniversity of Pennsylvania Health System (UPHS) data;*N* = 17,716In-hospital mortality or transition to hospice during 30-day readmissionsMixed-effects logistic regression for In-hospital death, or transition to hospice during 30-day read- missionsOlder age; Higher burden of comorbidities; Prior hospitalisations; Non-elective index admissionSepsisPresence of shockDischarge disposition not to home; Lower discharge; levels of haemoglobin; Lower Sodium concentrations; Higher discharge levels of RDW; Insurance statusDonnelly et al. \[[@CR12]\]USAUniversity Health System Consortium (UHC) data; *N* = 216,328Unplanned 7- and 30-day readmission after hospitalisation with severe sepsisMixed-effects logistic regression for 30-day rehospitalisationFemaleLonger index admission length of stayHigher burden of comorbiditiesDigestive system infection sites based on ICD-9 codesInstitutions with higher sepsis case volume and lower ICU utilisationGadre et al. \[[@CR35]\]USAHealthcare Cost and Utilisation Project National Readmissions data; *N* = 1,030,33530-day all-cause readmissionsMultivariable regression model with hospital as random effectComorbidities; Longer length of stayNo associations with shock or mechanical ventilationDischarge to short/long-term facility; Lower socioeconomic statusGoodwin et al. \[[@CR36]\]USAHealthcare Cost and Utilisation Project data; *N* = 43,45230-day readmission after hospitalisation with severe sepsisMultivariable logistic regression for 30-day rehospitalisationAge \< 80 yearsMaleBlackMedicare or Medicaid as primary payerComorbiditiesSepsis-specific effect lost significance once comorbidities were accountedDischarge disposition not to homeInstitutions with higher sepsis case volumeHigher in-hospital sepsis mortalityGuirgis et al. \[[@CR37]\]USAUniversity of Florida (UF) Health Jacksonville Emergency Department data; *N* = 110Long-term organ dysfunction in sepsis survivorsNoNot applicableNot applicableNot applicableHua et al. \[[@CR38]\]USANew York State-wide Planning and Research Cooperative System (SPARCS) data; *N* = 492,65330-day readmission after critical illnessCompeting risk regression for 30-day rehospitalisationOlder ageLonger index admission length of stayHigher burden of comorbidities including Dialysis dependence; Medicaid as primary payerOrgan dysfunction (described as severe sepsis)Discharge disposition not to homeTracheostomy at index admissionJones et al. \[[@CR39]\]USAUniversity of Pennsylvania Health System (UPHS) data; *N* = 3,620 sepsis and 108,958 non-sepsis30-day all-cause readmission after hospitalisation with sepsisMultivariable logistic regression for 30-day rehospitalisationLower age;Hospitalisation in previous yearnon-elective index admissionNo independent associations reportedLower discharge levels of haemoglobinHigher discharge levels of RDWKim et al. \[[@CR40]\]Republic of KoreaAsan Medical Centre data; *N* = 2062Risk factors of readmission due to sepsis caused by the "same organism" within 90 days of dischargeStepwise multivariate regression to identify risk factors for individual pathogenMale sex lowers riskSame site of infection; Gram-negative pathogen; UTINo independent association reportedLiu et al. \[[@CR41]\]USAKaiser Permanente Northern California data; *N* = 6,3441-year rehospitalisation/healthcare utilisation after hospitalisation with sepsisCompeting risk regression for 30-day rehospitalisationOlder age; Higher burden of comorbidities; Longer index admission length of stay;Illness severity at index admissionRequirement for ICU careMayr et al. \[[@CR42]\]USA2013 Nationwide readmission database; *N* = 147,084 sepsis patientsUnplanned 30-day readmission after sepsis hospitalisationNoNot applicableNot applicableNot applicableMeyer et al. \[[@CR43]\]USAUniversity of Pennsylvania Health System (UPHS); *N* = 17,256Temporal trends in sepsis survivorship and hospital-based acute care use in sepsis survivorsNoNot applicableNot applicableNot applicableNkemdirim Okere et al. \[[@CR44]\]USAFerris State University single-centre data; *N* = 661Length of stay; 30-, 60- and 90- day all-cause readmission after sepsis hospitalisationNoNot applicableNot applicableNot applicableNorman et al. \[[@CR45]\]USAMedicare database; *N* = 633,407All-cause 30-day readmission after hospitalisation with sepsisHospital-level risk-standardized 30-day all-cause readmission rates using regression modelsNo independent association reportedNo independent associations reportedTeaching hospitals; Hospitals providing care for high proportion of underserved patients; Northeast USA geographic regionNsutebu et al. \[[@CR46]\]England, UKAdvancing Quality Sepsis data; *N* = 7,776The outcomes of interest were inpatient mortality, readmission within 30 days and hospitalisation longer than 10 daysNoNot applicableNot applicableNot applicableOrtego et al. \[[@CR47]\]USAUniversity of Pennsylvania Health System (UPHS); *N* = 997All-cause hospital readmission/ED visits within 30 days of discharge after hospitalisation with septic shockMultivariable logistic regression for 30-day rehospitalisationMalignancy as comorbidityLength of stay greater than 4 daysNo independent associations reportedRecent hospitalisation within 30 daysPrescott et al. \[[@CR49]\]USAUS Health and Retirement Study Data; *N* = 16,772 participantsUse of inpatient facilities (hospitals; long-term acute care hospitals; skilled nursing facilities) in the year following discharge after sepsis hospitalisationNoNot applicableNot applicableNot applicablePrescott et al. \[[@CR9]\]USAUS Health and Retirement Study Data linked with Medicare claims data; *N* = 2,617 sepsis and 2,617 matched non-sepsis90-day readmission diagnoses after hospitalisation with severe sepsis compared to matched non-sepsis cohortsNoNot applicableNot applicableNot applicablePrescott et al. \[[@CR48]\]US Health and Retirement Study Data linked with Medicare claims data; *N* = 10,996 participantsSevere sepsis in 90 days following hospital dischargeNoNot applicableNot applicableNot applicablePrescott et al. \[[@CR13]\]USAUSA Veterans Affairs Database90-day all-cause readmissionhierarchical logistic regression with patients nested within hospitals for all-cause readmissionsAgeNo independent associations reportedDischarge to nursing facilitySchnegelsberg et al. \[[@CR50]\]DenmarkAarhus University Hospital, Denmark sepsis research database; *N* = 38730- and 180-day mortality; unplanned 180-day readmission after sepsis hospitalisationCox models adjusted for sex, comorbidity and SAPS II score for readmission or deathNo independent association reportedNo independent associations reportedLiving aloneSingh et al. \[[@CR51]\]USASaint Vincent Hospital data; *N* = 1,29730-day unplanned readmissionsMultivariable logistic regression for 30-day readmissionsPrior hospitalisation in preceding year;No independent associations reportedDischarge disposition to short-term rehab facility; Nursing home; Lower discharge haemoglobinSun et al. \[[@CR52]\]USAUniversity of Pennsylvania Health System (UPHS) data; *N* = 444Unplanned 30-day readmission after hospitalisation with sepsisMultivariable logistic regression for 30-day rehospitalisationPrior hospitalisation before index sepsis episodeNo independent associations reportedUse of Total parenteral nutrition; Longer duration of antibiotics; Lower discharge haemoglobinSutton et al. \[[@CR53]\]USAHealthcare Cost and Utilisation Project and State Inpatient database; *N* = 267,000 in 2005Trends in sepsis admissions and readmissions 2005---2010NoNot applicableNot applicableNot applicableVashi et al. \[[@CR54]\]USAHealthcare Cost and Utilization Project state inpatient and Emergency Department databases; *N* = 81,943 sepsisED visits (not resulting in admission); hospital readmissions from any source; combined measure of ED visits and hospital readmissionNoNot applicableNot applicableNot applicableWang et al. \[[@CR55]\]USAWest Los Angeles Veteran Affairs (VA) Healthcare Centre, *N* = 78 sepsis and 50 non-sepsisRecurrent infections in first year following hospitalisation with sepsisIndependent-incremental models for recurrent infection events related rehospitalisationAdvanced age, Admission from nursing home;No independent associations reportedProlonged hospitalisation; presence of indwelling catheterWeinreich et al. \[[@CR56]\]USATexas Southwestern Medical Centre data; *N* = 1,355 sepsisAll-cause 30- day readmissionsMultivariate logistic regression was used to identify factors associated with 30-day readmissionsComorbidities (Malignancy, renal disease and cirrhosis)Bacteraemia during index sepsis admission;Discharged with an indwelling vascular catheterWong et al. \[[@CR57]\]Hong KongHong Kong Hospital Authority Database; *N* = 337,69430-day readmission after index hospitalisation with ten common medical conditionsNoNot applicableNot applicableNot applicableYende et al. \[[@CR58]\]USAProspective Cohort Study; *N* = 4831-year included all-cause and cause-specific readmissions and mortalityNoNot applicableNot applicableNot applicableZilberberg et al. \[[@CR59]\]USABarnes-Jewish Hospital data; *N* = 1,697All-cause 30-day readmission after hospitalisation with severe sepsis or septic shockMultivariable logistic regression for 30-day rehospitalisationNo independent association reportedPresence of ESBL or Bacteroides spp; Acute Kidney injury; UTINo independent association reported*USA* United States of America, *ADL* activities of daily living, *ED* emergency department, *RDW* red cell distribution width, *CLABSI* Catheter-related blood stream infection, *VAP* ventilator-associated pneumonia, *COPD* chronic obstructive pulmonary disease, *UTI* urinary tract infections, *ICU*intensive care unit, *ESBL* extended spectrum beta-lactamase

Among the sepsis-specific characteristics at index admission, infection features, organ dysfunction, and illness severity were identified as risk factors for rehospitalisation, especially when assessed with competing risk regression models \[[@CR38], [@CR41]\]. The type of infecting pathogen at index admission did not significantly alter the risk of rehospitalisation, with the exception of extended spectrum beta-lactamase (ESBL) producing bacteria \[[@CR59]\]. When risk factors for the same pathogen as index sepsis admission for rehospitalisation were evaluated, same pathogen was identified only in 25% of rehospitalisation and the major risk factors for same pathogen rehospitalisation were Gram-negative bacteria, urosepsis, and same site of infection \[[@CR40]\]. Similar to all-cause rehospitalisation, the risk factors for infection-related rehospitalisation were older age, prolonged hospitalisation, and nursing home residence \[[@CR55]\]. In three studies, infection-related rehospitalisation episodes were associated with greater risk of death \[[@CR32], [@CR52], [@CR55]\] when compared to non-infection-related hospitalisations.

Among hospital-level characteristics, risk of rehospitalisation in sepsis survivors varied significantly among hospitals in two studies \[[@CR12], [@CR29]\] and did not in one study \[[@CR13]\]. The risk of rehospitalisation in sepsis survivors was higher in hospitals serving a higher proportion of minority population, in for profit hospitals compared with public/non-profit hospitals, in university or teaching hospitals vs. not, in hospitals that had higher sepsis case volume especially when associated with lower critical care usage, and in hospitals that had higher in-hospital mortality for sepsis index sepsis admissions \[[@CR12], [@CR29], [@CR36], [@CR45]\].

In studies with non-sepsis comparator populations, there were similarities in generic and hospital-level characteristics as risk factors for rehospitalisation in sepsis survivors and rehospitalisation seen with medical conditions such as congestive heart failure and acute myocardial infarction \[[@CR29], [@CR54]\]. Eight other studies report regression models that were not aimed at identifying rehospitalisation risk factors, but were designed to examine health care utilization \[[@CR33]\], long-term organ dysfunction \[[@CR37]\], effect of statins \[[@CR44]\], subsequent severe sepsis following index all-cause hospitalization \[[@CR48]\], variation in patterns of rehospitalization in sepsis survivors \[[@CR13]\], additional risk of socioeconomic status in sepsis \[[@CR50]\], and risk of sepsis compared to non-sepsis hospitalizations \[[@CR55], [@CR57]\].

Overall certainty of evidence {#Sec15}
-----------------------------

For the primary outcome of all-cause rehospitalisation, the certainty of evidence is moderate, based on low risk of bias in the majority of studies reporting 30-day rehospitalisation. We did not rate down further for imprecision or inconsistency, because confidence intervals around risks of rehospitalisation were reasonably narrow and compatible with clinically important risks. Studies generally had broad inclusion criteria representative of the exposure of interest, sepsis, and, therefore, provided direct evidence. There was no evidence of publication bias. For rehospitalisation risk factors, the certainty of evidence is low due to inconsistency in risk factor definitions, imprecision in strengths of association, and risk of bias in many studies due to lack of competing risk models.

Discussion {#Sec16}
==========

One in five sepsis survivors are re-hospitalised within 30 days of discharge from hospital. The cumulative proportion of sepsis survivors re-hospitalised plateaus at 40% between 90 and 365 days, which may be related to competing risk of long-term deaths in sepsis survivors. Only two studies considered competing risk of long-term mortality when studying risk factors for rehospitalisation in sepsis survivors. The most common rehospitalisation diagnosis in sepsis survivors was infection. Uncertainties remain as to whether this represents a new infection or recurring infection from the index sepsis admission. Independent risk factors of rehospitalisation were most often time-invariant predictors like older age, male sex, higher comorbidity burden, and hospitalisation immediately preceding the index sepsis admission, and discharge to non-home location. Among the sepsis-specific risk factors, gastrointestinal site of infection, infection with ESBL bacteria, increasing illness severity, and longer hospital length of stay during index admission increased the risk of rehospitalisation. Other characteristics that increased rehospitalisation risk were lower socioeconomic strata, lower discharge haemoglobin, use of total parenteral nutrition, and tracheostomy at index sepsis admission. Hospital-level characteristics such as for profit and university status and sepsis volumes also influenced the risk of rehospitalisation in sepsis survivors, albeit inconsistently.

Ours is first systematic review of the epidemiology of rehospitalisation events in the at-risk population of adult sepsis survivors, in the year following sepsis-related hospitalisation. We used a customized checklist to assess potential for bias in ascertainment of exposure, the outcome, and management of confounding. We limited the study population to adult sepsis survivors and the outcome to all-cause rehospitalisation. We report the rehospitalisation rates at different timepoints over the first year following sepsis survival. Our systematic review describes the excess risk of sepsis-related rehospitalisation up to 1 year, which will inform sample size estimations of trials focussing on sepsis survivors and when assessed within health care systems could inform follow-up care planning.

There are limitations to this systematic review. The rehospitalisation events and diagnoses were identified in most studies using data linkage. Although we excluded non-English language studies, this is unlikely to bias our results \[[@CR80], [@CR81]\]. We did not extract length of hospital stay data. The lack of any RCTs included in our systematic review may be related to the search strategy and screening criteria that focused on rehospitalisation events in sepsis survivors; we did not systematically examine all trials of septic patients to determine whether they reported rehospitalisation data. As the diagnostic codes are linked to hospital activity and remuneration, potential risk of bias from different coding practices cannot be ruled out. As our goal was to assess sepsis survivors' risk of rehospitalisation, we excluded related conditions such as pneumonia \[[@CR82]\] which could potentially have provided additional information on rehospitalisation risk factors. In a systematic review of that specifically addressed rehospitalisation after pneumonia, the 30-day all-cause rehospitalisation rates in 12 studies were 11.6%, which is lower than sepsis survivor rates which we observed \[[@CR83]\]. Interestingly, the 1-year rehospitalisation rates following pneumonia was 46%, which is compared to the sepsis survivor rates which we observed \[[@CR83]\]. Higher rehospitalisation rates following pneumonia were noted in US-based cohorts and the common reasons for rehospitalisation following pneumonia in the study were pneumonia (5.6%) and worsening of cardiac and pulmonary comorbidities \[[@CR83]\]. We planned our study before guidelines for systematic reviews assessing prognostic factors were published \[[@CR84]\]. Most studies have assessed rehospitalisation risk using previous definitions of sepsis or using ICD codes to identify sepsis. Thus, our study highlights that rehospitalisation epidemiology with a more recent sepsis survivor cohort, based on the updated sepsis definitions, would be a valuable addition to the literature \[[@CR1], [@CR85]\].

We categorised the rehospitalisation risk factors or predictors into generic, sepsis-specific, and hospital-level risk factors. We show that many of the risk factors for rehospitalisation are time-invariant predictors such as age, comorbidity, prior hospitalisation, site of infection at admission, and socioeconomic or deprivation status \[[@CR29], [@CR44], [@CR50]\] such as insurance, lower income, urban residence, race, and education. These predictors have also been identified as risk factors for long-term mortality \[[@CR6], [@CR10]\] and are commonly available when sepsis survivors leave hospital. Therefore, a parsimonious prognostic risk score could be derived to stratify sepsis survivors based on their rehospitalisation risk, using their index sepsis admission variables. Our review also highlights the value of explicitly considering competing risk models in the analysis when assessing risk factors, as the cumulative rehospitalisation proportion plateaus after 90 days, potentially due to long-term mortality acting as competing event for rehospitalisation, especially in health care settings where community-level end-of-life or hospice care are more prevalent \[[@CR18], [@CR19]\].

Sepsis-specific characteristics such as features of infection and sepsis severity requiring critical care admission influenced this rehospitalisation risk \[[@CR12], [@CR34], [@CR41], [@CR59]\]. Furthermore, in our study, the most common rehospitalisation diagnosis in sepsis survivors was infection, which has been linked to microbiome alterations \[[@CR48]\] and to immunological sequelae seen in sepsis survivors \[[@CR58], [@CR86]\]. Thus, understanding the microbiome and immunological status at critical care discharge will enable design of potential interventional trials in this population \[[@CR8]\].

Hospital-level characteristics also influenced the risk of rehospitalisation in sepsis survivors, albeit inconsistently. Hospital sepsis case volume and critical care usage of sepsis patients influences subsequent rehospitalisation risk \[[@CR36]\]. Furthermore, characteristics such as hospital size, university status, and serving a minority population appear to influence the risk of rehospitalisation. Thus, there is a need to assess the relative contributions of hospital- and patient-level predictors for this rehospitalisation risk, as reported for cardiovascular diseases \[[@CR11]\]. These may provide opportunities for addressing this rehospitalisation problem with hospital-level quality-of-care interventions. For example, understanding how best to manage medical comorbidities in sepsis survivors \[[@CR9]\] could alter the long-term risk of rehospitalisation and death.

Conclusions {#Sec17}
===========

One in five sepsis survivors are re-hospitalised within 30 days of discharge from hospital and this rehospitalisation risk is comparable with non-sepsis acute medical conditions. Generic patient characteristics (such as increasing age, comorbidity burden, and haemoglobin at discharge from hospital), sepsis-specific characteristics (such as type of infection), and hospital-level characteristics at their index sepsis admission influence this rehospitalisation risk. Our findings may inform the development of prognostic scores and the design of future interventional studies in this at-risk population of sepsis survivors.
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